Nicotine By-Product Can Predict Recurrence of Cancer
San Francisco, CA (UroToday.com) — A by-product of nicotine, found in the urine of smokers, could be used to identify when bladder cancer has returned, new research has found.
EAU 2021: Neoadjuvant Chemotherapy in Upper Urothelial Cancer
(UroToday.com) Dr. Mohammad Abufaraj from Jordan University Hospital discussed neoadjuvant chemotherapy for upper tract urothelial carcinoma at the joint session of the European Association of Urology (EAU) and the Arab Association of Urology. Dr. Abufaraj started by highlighting that urothelial carcinoma is the 5th most frequent cancer diagnosed in the United States, with upper tract urothelial […]
EAU 2021: Lymphadenectomy for Prostate Cancer: When and How?
(UroToday.com) At the European Association of Urology (EAU) 2021 Annual Meeting, Dr. Axel Heidenreich discussed when and how to perform lymphadenectomy for prostate cancer at the joint session of the EAU and the Confederacion Americana De Urologica. Dr. Heidenreich notes that the rationale of pelvic lymphadenectomy is to (i) identify micrometastatic spread to locoregional lymph nodes, […]
EAU 2021: Risk-Adapted Screening with Age and Baseline-PSA: PROBASE Trial
(UroToday.com) Dr. Christian Arson of Düsseldorf Germany presents on the PROBASE trial, a risk-adapted screening study for prostate cancer based on age and baseline PSA alone. This is a preliminary presentation of early results for an ongoing study.
EAU 2021: Risk-adapted screening with 4K and MRI: PROSCREEN Trial
(UroToday.com) Dr. Anssi Auvinen of Finland presented the PROSCREEN trial, which is an ongoing risk-adapted screening based on 4K score and MRI.
EAU 2021: How Relevant Are Advances in Optics in the Visualization of NMIBC?
(UroToday.com) The joint session of the European Association of Urology (EAU) and the Maghreb Union Countries included a bladder cancer session and presentation by Dr. Mohamed Tetou discussing advances in optics in the visualization of non-muscle invasive bladder cancer (NMIBC).
EAU 2021: What Are the Main Steps to Optimal TURBT?
(UroToday.com) The joint session of the European Association of Urology (EAU) and the Maghreb Union Countries included a presentation by Dr. Maximilian Burger who discussed the main steps of an optimal transurethral resection of a bladder tumor (TURBT). Dr. Burger highlighted that the main steps to an optimal TURBT are to (i) appreciate the patient, (ii) […]
EAU 2021: Prostate Cancer Screening 2021 Algorithm
(UroToday.com) Dr. Monique Roobol, one of the session chairs, kicked off the update session with a summary of the current state of PSA screening in Europe followed by the recently published recommended screening algorithm by the EAU. This algorithm has recently been published and the reference can be found below.1
EAU 2021: Will MRI Transform the Management of Muscle Invasive Bladder Cancer?
(UroToday.com) The joint session of the European Association of Urology and the Maghreb Union Countries included a bladder cancer session and presentation by Dr. Valeria Panebianco discussing the role of MRI in the management of muscle invasive bladder cancer. The diagnostic workup in patients with confirmed muscle invasive bladder cancer includes either CT urogram or MRI, […]
EAU 2021: Surgical Treatment of Lymph Node Recurrences After Radical Prostatectomy – Pro Radiotherapy
(UroToday.com) The joint session of the European Association of Urology and the Confederacion Americana de Urologia included a session discussing the surgical treatment of lymph node recurrences after radical prostatectomy. Dr. Piet Ost from Ghent University Hospital in Belgium took the pro radiotherapy approach for his presentation.